These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38184121)

  • 1. The determinants of metabolic discrepancies in aerobic glycolysis: Providing potential targets for breast cancer treatment.
    Littleflower AB; Parambil ST; Antony GR; Subhadradevi L
    Biochimie; 2024 May; 220():107-121. PubMed ID: 38184121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of aerobic glycolysis in breast cancer.
    Wu Z; Wu J; Zhao Q; Fu S; Jin J
    Clin Transl Oncol; 2020 May; 22(5):631-646. PubMed ID: 31359335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycolysis Inhibitors for Anticancer Therapy: A Review of Recent Patents.
    Sheng H; Tang W
    Recent Pat Anticancer Drug Discov; 2016; 11(3):297-308. PubMed ID: 27087655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells.
    Fukushi A; Kim HD; Chang YC; Kim CH
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of imatinib and clotrimazole enhances cell growth inhibition in T47D breast cancer cells.
    Motawi TM; Sadik NA; Fahim SA; Shouman SA
    Chem Biol Interact; 2015 May; 233():147-56. PubMed ID: 25863232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling cancer glycolysis under hypoglycemia, and the role played by the differential expression of glycolytic isoforms.
    Marín-Hernández A; López-Ramírez SY; Del Mazo-Monsalvo I; Gallardo-Pérez JC; Rodríguez-Enríquez S; Moreno-Sánchez R; Saavedra E
    FEBS J; 2014 Aug; 281(15):3325-45. PubMed ID: 24912776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Update on Patents Covering Agents That Interfere with the Cancer Glycolytic Cascade.
    Fortunato S; Bononi G; Granchi C; Minutolo F
    ChemMedChem; 2018 Nov; 13(21):2251-2265. PubMed ID: 30226288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
    Knouzy B; Dubourg L; Baverel G; Michoudet C
    J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining and understanding the control of glycolysis in fast-growth tumor cells. Flux control by an over-expressed but strongly product-inhibited hexokinase.
    Marín-Hernández A; Rodríguez-Enríquez S; Vital-González PA; Flores-Rodríguez FL; Macías-Silva M; Sosa-Garrocho M; Moreno-Sánchez R
    FEBS J; 2006 May; 273(9):1975-88. PubMed ID: 16640561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting cellular metabolism to improve cancer therapeutics.
    Zhao Y; Butler EB; Tan M
    Cell Death Dis; 2013 Mar; 4(3):e532. PubMed ID: 23470539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis.
    Arundhathi JRD; Mathur SR; Gogia A; Deo SVS; Mohapatra P; Prasad CP
    Mol Biol Rep; 2021 May; 48(5):4733-4745. PubMed ID: 34047880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycolysis inhibition for anticancer treatment.
    Pelicano H; Martin DS; Xu RH; Huang P
    Oncogene; 2006 Aug; 25(34):4633-46. PubMed ID: 16892078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation.
    Marín-Hernández A; Gallardo-Pérez JC; López-Ramírez SY; García-García JD; Rodríguez-Zavala JS; Ruiz-Ramírez L; Gracia-Mora I; Zentella-Dehesa A; Sosa-Garrocho M; Macías-Silva M; Moreno-Sánchez R; Rodríguez-Enríquez S
    Arch Toxicol; 2012 May; 86(5):753-66. PubMed ID: 22349057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
    Lu CL; Qin L; Liu HC; Candas D; Fan M; Li JJ
    PLoS One; 2015; 10(3):e0121046. PubMed ID: 25807077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells.
    Zancan P; Sola-Penna M; Furtado CM; Da Silva D
    Mol Genet Metab; 2010 Aug; 100(4):372-8. PubMed ID: 20483646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of culture conditions, culture media volumes, and glucose content on metabolic properties of renal epithelial cell cultures. Are renal cells in tissue culture hypoxic?
    Gstraunthaler G; Seppi T; Pfaller W
    Cell Physiol Biochem; 1999; 9(3):150-72. PubMed ID: 10494029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment.
    Xintaropoulou C; Ward C; Wise A; Queckborner S; Turnbull A; Michie CO; Williams ARW; Rye T; Gourley C; Langdon SP
    BMC Cancer; 2018 Jun; 18(1):636. PubMed ID: 29866066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous normal mammary epithelial mitochondria suppress glycolytic metabolism and glucose uptake of human breast cancer cells.
    Jiang XP; Elliott RL; Head JF
    Breast Cancer Res Treat; 2015 Oct; 153(3):519-29. PubMed ID: 26407856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Key Transporters in Tumor Glycolysis as a Novel Anticancer Strategy.
    Shi Y; Liu S; Ahmad S; Gao Q
    Curr Top Med Chem; 2018; 18(6):454-466. PubMed ID: 29788889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.